Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases

  • ACS Med Chem Lett. 2025 Apr 2;16(5):732-733. doi: 10.1021/acsmedchemlett.5c00165.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
PMID: 40365385 DOI: 10.1021/acsmedchemlett.5c00165
Abstract

Provided herein are novel bicyclic heterocycles as MRGPRX2 antagonists, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.

Products